vTv Therapeutics Inc’s recent filing unveils that its Pres, CEO and Exec Chairperson SEKHRI PAUL J acquired Company’s shares for reported $52543.0 on Nov 15 ’24. In the deal valued at $16.65 per share,3,156 shares were bought. As a result of this transaction, SEKHRI PAUL J now holds 3,156 shares worth roughly $71767.44.
Then, SEKHRI PAUL J bought 1,844 shares, generating $31,269 in total proceeds. Upon buying the shares at $16.96, the Pres, CEO and Exec Chairperson now owns 5,000 shares.
H.C. Wainwright initiated its vTv Therapeutics Inc [VTVT] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early April from “a Buy” to “a Hold”. ROTH Capital began covering VTVT with “Buy” recommendation on March 08, 2018. Northland Capital started covering the stock on February 08, 2018. It rated VTVT as “an Outperform”.
Price Performance Review of VTVT
On Monday, vTv Therapeutics Inc [NASDAQ:VTVT] saw its stock jump 53.13% to $22.74. Over the last five days, the stock has gained 51.60%. vTv Therapeutics Inc shares have risen nearly 64.68% since the year began. Nevertheless, the stocks have risen 53.03% over the past one year. While a 52-week high of $30.99 was reached on 03/17/25, a 52-week low of $12.12 was recorded on 01/14/25. SMA at 50 days reached $16.45, while 200 days put it at $16.56.
Levels Of Support And Resistance For VTVT Stock
The 24-hour chart illustrates a support level at 17.83, which if violated will result in even more drops to 12.92. On the upside, there is a resistance level at 27.32. A further resistance level may holdings at 31.90. The Relative Strength Index (RSI) on the 14-day chart is 68.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 34.10%. Stochastics %K at 24.10% indicates the stock is a holding.
How much short interest is there in vTv Therapeutics Inc?
A steep rise in short interest was recorded in vTv Therapeutics Inc stocks on 2025-02-28, dropping by 2627.0 shares to a total of 24089.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 26716.0 shares. There was a decline of -10.91%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 26, 2016 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $13 price target.
